MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease
- PMID: 11583755
- DOI: 10.1016/s0140-6736(01)06125-6
MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease
Abstract
Up to half of patients with Graves' hyperthyroidism have signs of thyroid associated ophthalmopathy, but the factors that cause this disorder are unknown. We investigated two major genetic susceptibility loci for Graves' disease in ophthalmopathy; the MHC class II region and the cytotoxic T lymphocyte antigen-4 (CTLA4) gene. Allelic frequencies of these genes in patients with Graves' disease who did and did not have concurrent thyroid-associated ophthalmopathy did not differ, and are, therefore, unlikely to contribute to its development.
Similar articles
-
Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.Thyroid. 2000 Sep;10(9):791-8. doi: 10.1089/thy.2000.10.791. Thyroid. 2000. PMID: 11041456
-
Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations.Eur J Endocrinol. 2003 Jan;148(1):13-8. doi: 10.1530/eje.0.1480013. Eur J Endocrinol. 2003. PMID: 12534352
-
Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.J Zhejiang Univ Sci B. 2006 Nov;7(11):887-91. doi: 10.1631/jzus.2006.B0887. J Zhejiang Univ Sci B. 2006. PMID: 17048303 Free PMC article.
-
The genetics of Graves' disease.Endocrinol Metab Clin North Am. 2000 Jun;29(2):255-66. doi: 10.1016/s0889-8529(05)70130-4. Endocrinol Metab Clin North Am. 2000. PMID: 10874528 Review.
-
Genetic determinants of Graves disease.Mol Genet Metab. 2000 Sep-Oct;71(1-2):66-9. doi: 10.1006/mgme.2000.3042. Mol Genet Metab. 2000. PMID: 11001797 Review.
Cited by
-
Graves' ophthalmopathy: a review of immunogenetics.Curr Genomics. 2011 Dec;12(8):564-75. doi: 10.2174/138920211798120844. Curr Genomics. 2011. PMID: 22654556 Free PMC article.
-
TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.J Endocrinol Invest. 2015 May;38(5):555-61. doi: 10.1007/s40618-014-0228-9. Epub 2014 Dec 28. J Endocrinol Invest. 2015. PMID: 25543543
-
Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond.Clin Exp Immunol. 2004 Apr;136(1):1-10. doi: 10.1111/j.1365-2249.2004.02424.x. Clin Exp Immunol. 2004. PMID: 15030506 Free PMC article. Review.
-
Association between the CTLA-4 +49A/G polymorphism and Graves' disease: A meta-analysis.Exp Ther Med. 2012 Sep;4(3):538-544. doi: 10.3892/etm.2012.618. Epub 2012 Jun 20. Exp Ther Med. 2012. PMID: 23181132 Free PMC article.
-
[Endocrine orbit disorders. Pathogenesis, clinical presentation and examination, stage-dependent therapy].Ophthalmologe. 2003 Oct;100(10):857-80. doi: 10.1007/s00347-003-0873-4. Ophthalmologe. 2003. PMID: 14986660 Review. German. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials